Ayrshire Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Hold |
5,400
| – | – | 0.29% | 36 |
|
|
2025
Q1 | $605K | Sell |
5,400
-15
| -0.3% | -$1.68K | 0.29% | 37 |
|
|
2024
Q4 | $500K | Buy |
5,415
+15
| +0.3% | +$1.39K | 0.24% | 38 |
|
|
2024
Q3 | $453K | Hold |
5,400
| – | – | 0.22% | 43 |
|
|
2024
Q2 | $370K | Hold |
5,400
| – | – | 0.19% | 46 |
|
|
2024
Q1 | $396K | Hold |
5,400
| – | – | 0.21% | 42 |
|
|
2023
Q4 | $437K | Hold |
5,400
| – | – | 0.25% | 41 |
|
|
2023
Q3 | $405K | Hold |
5,400
| – | – | 0.26% | 40 |
|
|
2023
Q2 | $414K | Hold |
5,400
| – | – | 0.26% | 39 |
|
|
2023
Q1 | $448K | Hold |
5,400
| – | – | 0.31% | 40 |
|
|
2022
Q4 | $464K | Hold |
5,400
| – | – | 0.32% | 40 |
|
|
2022
Q3 | $333K | Hold |
5,400
| – | – | 0.25% | 41 |
|
|
2022
Q2 | $334K | Hold |
5,400
| – | – | 0.24% | 46 |
|
|
2022
Q1 | $321K | Hold |
5,400
| – | – | 0.19% | 49 |
|
|
2021
Q4 | $392K | Hold |
5,400
| – | – | 0.2% | 46 |
|
|
2021
Q3 | $377K | Hold |
5,400
| – | – | 0.21% | 47 |
|
|
2021
Q2 | $372K | Hold |
5,400
| – | – | 0.21% | 49 |
|
|
2021
Q1 | $349K | Hold |
5,400
| – | – | 0.21% | 49 |
|
|
2020
Q4 | $315K | Hold |
5,400
| – | – | 0.2% | 55 |
|
|
2020
Q3 | $341K | Hold |
5,400
| – | – | 0.25% | 55 |
|
|
2020
Q2 | $415K | Hold |
5,400
| – | – | 0.35% | 52 |
|
|
2020
Q1 | $404K | Hold |
5,400
| – | – | 0.41% | 55 |
|
|
2019
Q4 | $351K | Buy |
+5,400
| New | +$351K | 0.29% | 60 |
|